CASI Pharmaceuticals, Inc.
CASI News Today: Stay Updated with the Latest CASI Pharmaceuticals, Inc. News in Real Time
Find CASI news now at Meyka AI. Stay informed with the latest CASI Pharmaceuticals, Inc. stocks updates, including price news, market analysis, and expert insights.
BofA Securities Upgrades Teladoc Health, Inc. (TDOC) to Buy Feb 26, 2026
Bank of America upgrades Teladoc; TDOC analyst rating moved to Buy with a $7 price target
ECOX Eco Innovation Group (PNK) $0.00035 heavy volume 27 Feb 2026: liquidity
ECOX stock update: trading $0.00035 on heavy volume; analysis of volume, fundamentals and Meyka AI forecast
BAYN.DE Bayer AG (XETRA) pre-market: earnings due 04 Mar 2026, guidance key
Pre-market BAYN.DE stock preview ahead of 04 Mar 2026 earnings; key metrics, Meyka AI forecast and price targets
PATH (UiPath, NYSE) closes at $10.10 on 26 Feb 2026: AI pivot tests valuation
PATH stock: UiPath closes $10.10 on 26 Feb 2026, Meyka AI outlook and forecast
Barclays Maintains Overweight on C4 Therapeutics (CCCC) Feb 26, 2026
Barclays and Cowen maintain ratings on C4 Therapeutics. Read Feb 26, 2026 CCCC analyst rating and implications
NWTT stock: NW Tech Capital (NWTT) PNK trades at $0.00010 in US market hours 26 Feb 2026: watch liquidity and downside
NWTT stock trades at $0.00010 on PNK 26 Feb 2026. Meyka AI grade B, HOLD; model projects -84.21% vs current price
Bank of America Maintains Buy on eBay Inc. (EBAY) Feb 26, 2026
Bank of America keeps Buy on eBay. Read the latest EBAY analyst rating, market reaction, and Meyka grade B+
Up 33.33% today: BURY.CN Burrell Resources Inc. (CNQ) 26 Feb 2026: Antelope option fuels momentum
BURY.CN stock jumps 33.33% to C$0.14 on Feb 26, 2026; we review catalysts, valuation and Meyka AI forecast
Leerink Maintains Outperform on Vir Biotechnology, Inc. (VIR) Feb 2026
Leerink keeps Outperform and raises PT to $20. VIR analyst rating update and implications for investors